PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.92%
Similar revenue growth to VET's 2.71%. Walter Schloss would investigate if similar growth reflects similar quality.
4.48%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
1.42%
Gross profit growth below 50% of VET's 4.40%. Michael Burry would check for structural issues.
-1.46%
Margin decline while VET shows 1.65% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.40%
Other expenses change of 1.40% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
2.81%
Operating expenses growth less than half of VET's 7.74%. David Dodd would verify sustainability.
3.86%
Similar total costs growth to VET's 3.63%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
-6.47%
D&A reduction while VET shows 13.22% growth. Joel Greenblatt would examine efficiency.
-6.50%
EBITDA decline while VET shows 6.18% growth. Joel Greenblatt would examine position.
27.50%
EBITDA margin growth exceeding 1.5x VET's 3.38%. David Dodd would verify competitive advantages.
-0.43%
Operating income decline while VET shows 1.63% growth. Joel Greenblatt would examine position.
-3.26%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-434.26%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-50.42%
Pre-tax income decline while VET shows 1.91% growth. Joel Greenblatt would examine position.
-51.83%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-12.67%
Tax expense reduction while VET shows 30.99% growth. Joel Greenblatt would examine advantage.
-57.44%
Both companies show declining income. Martin Whitman would check industry conditions.
-58.65%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-58.54%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-58.75%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
3.43%
Share count increase while VET reduces shares. John Neff would investigate differences.
2.60%
Diluted share increase while VET reduces shares. John Neff would investigate differences.